
Eli Lilly ends antibody trial early after failed to help in recovery
Eli Lilly ends paused trial of antibody drug and remdesivir after the NIH found the combo failed to help recovery of hospitalized patients Eli Lilly & Co and the National Institues of Health announced they are ending a clinical trial of antibody drug The study was looking at a combination of the antibody, LY-CoV555, and remdesivir as a treatment for hospitalized coronavirus […]
Read more